Speak with any derivatives trading head at the investment banking arm of Switzerland’s largest bank, UBS, and they’ll be quick to tell you why they rarely take on large concentrations of highly exotic exposures. “Because risk management won’t allow it,” is the typical reply.
Although the Swiss banking group has ramped up its risk limits this year, along with a number of prominent dealers such as Goldman Sachs and JP Morgan Chase, UBS has made risk management a consistent core business priority
- Quant Finance Master’s Guide 2019
- People moves: SocGen adds in prime services, Deutsche fills new rates hole, HSBC makes model move, and more
- Podcast: Kenyon and Berrahoui on the pitfalls of PFE
- Cross-currency swaps could hasten RFR shift in Australia
- EU parliament OKs no-action powers but leaked doc signals delay